Laghlam, D.; Chaba, A.; Tarneaud, M.; Charpentier, J.; Mira, J.-P.; Pène, F.; Vigneron, C.
Survival Benefit of Renin-Angiotensin System Blockers in Critically Ill Cancer Patients: A Retrospective Study. Cancers 2023, 15, 3183.
https://doi.org/10.3390/cancers15123183
AMA Style
Laghlam D, Chaba A, Tarneaud M, Charpentier J, Mira J-P, Pène F, Vigneron C.
Survival Benefit of Renin-Angiotensin System Blockers in Critically Ill Cancer Patients: A Retrospective Study. Cancers. 2023; 15(12):3183.
https://doi.org/10.3390/cancers15123183
Chicago/Turabian Style
Laghlam, Driss, Anis Chaba, Matthias Tarneaud, Julien Charpentier, Jean-Paul Mira, Frédéric Pène, and Clara Vigneron.
2023. "Survival Benefit of Renin-Angiotensin System Blockers in Critically Ill Cancer Patients: A Retrospective Study" Cancers 15, no. 12: 3183.
https://doi.org/10.3390/cancers15123183
APA Style
Laghlam, D., Chaba, A., Tarneaud, M., Charpentier, J., Mira, J.-P., Pène, F., & Vigneron, C.
(2023). Survival Benefit of Renin-Angiotensin System Blockers in Critically Ill Cancer Patients: A Retrospective Study. Cancers, 15(12), 3183.
https://doi.org/10.3390/cancers15123183